New Evidence Sheds Light on Stem Cell Transplantation for Progressive MS
(MedPage Today) -- Autologous hematopoietic stem cell transplantation (AHSCT) was not superior in preventing relapses or reducing disability progression than natalizumab (Tysabri) in progressive multiple sclerosis (MS), new research suggested...
Source: MedPage Today Neurology - Category: Neurology Source Type: news
More News: Brain | Disability | Multiple Sclerosis | Neurology | Stem Cell Therapy | Stem Cells | Transplants | Tysabri